The reason for the recall is failed impurities or degradation specifications, it added.

For the 12 months to September 2018, DermaSmoothe/FS Topical Oil, 0.01 per cent (scalp oil), achieved annual sales of around USD 14 million...

The company's current portfolio consists of 146 products authorised for distribution at the US marketplace and 54 abbreviated new drug appl...